Pharmacy News and Stories

The Colorado Consortium for Prescription Drug Abuse Prevention, housed in the Skaggs School of Pharmacy and Pharmaceutical Sciences, is part of a state-wide coalition recognized with a first-of-its-kind award. The John’s Hopkins Bloomberg School of Public Health issued its first official recognition of Excellence in the Application of the Opioid Litigation Principles to the State of Colorado for distinction in incorporating the Opioid Litigation Principles into its process for distribution of national opioid litigation settlement funds.

Brad Bobel | May 08, 2023

Jeff Gold, PharmD, has a name fit for the bright lights, whether it’s the lights of a film crew, or the lights of a professional wrestling match. Those film lights found him for the Netflix documentary, “Take Your Pills: Xanax”, as he is a leading psychiatric pharmacist at the Veterans Affairs Medical Center in Aurora, Colorado and a specialist on medications like Xanax and other benzodiazepines.

Brad Bobel | February 06, 2023

The Skaggs School of Pharmacy and Pharmaceutical Sciences is excited to welcome Dr. Manisha Patel as the new Associate Dean for Research and Graduate Studies. With her 20 years of research experience, Dr. Patel is bringing a range of experiences and passion for answering the unknown. 

Brad Bobel | January 24, 2023

Pharmacists at the Skaggs School of Pharmacy and Pharmaceutical Sciences are leading the charge in the field of pharmacogenomics with their knowledge of how genetics influence how drugs work in the body.

Brad Bobel | January 09, 2023

The Skaggs School of Pharmacy and Pharmaceutical Sciences’ (CU Pharmacy) faculty have a long history of holding leadership positions throughout the country. Associate Dean of Student Affairs, Brian Hemstreet, PharmD, has recently joined that list after being elected President of the American College of Clinical Pharmacy (ACCP). Just like how his hobbies of biking and skiing take him to the mountains, he will be bringing his leadership skills to new heights.

Brad Bobel | November 29, 2022